Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Intera Partners in connection with the acquisition of Halon Security
Mandate

Vinge advises Intera Partners in connection with the acquisition of Halon Security

November 05, 2024 M&A Corporate Commercial Employment and Benefits Intellectual Property Banking and Finance

Vinge has advised Intera Equity Partners IV Oy (“Intera Partners”) in connection with the acquisition of Halon Security AB (“Halon”).

Halon is a global leader in email infrastructure software based in Sweden with customers in over 30 countries and a revenue of approximately SEK 49 million.

Halon is a trusted partner for mission-critical email services and service providers and companies that demand high security, scalability and high-volume email handling rely on Halon’s software. Intera Partners‘ investment will contribute to Halon's continued market expansion and development of solutions that meet customers’ changing needs and evolving business, technology and security requirements.

Vinge’s team consisted of among others Jonas Bergström, Carl Sander, Eléonore Friberg, Klara Fäldt and Emma Lundberg (M&A), Helena Göransson, Karl-Gustaw Tobola and Matilda Hamner (Banking and Finance) Jolene Reimerson and Carla Håkansson (Corporate Commercial & IT), Victor Björkheim (Employment), Emma Gustavsson (IP) and Cecilia Loctander (Transaction Support Coordinator).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025